ABSTRACT
Objective: Interferon therapy is widely used for patients with chronic viral hepatitis B and C (CHB-C). It is known that thyroid gland dysfunction (TD) may develop secondary to interferon treatment, but different frequencies of TD development are reported in the literature. For this reason, we aimed to investigate the incidence of TD developing secondary to interferon treatment in patients with CHB-C treated in our clinic and possible influence factors.
Methods: A total of 93 CHB-C patients treated with interferon were included in this study. Tests of thyroid functions (TSH, FT3, FT4), thyroid auto-antibodies (Anti-Tg, Anti-TPO) were done before starting interferon treatment, during and after treatment. Patients who did not have normal thyroid gland functions were not included in this study.
Results: TD was observed to develop in a total of 20 patients (21.5%). TD had developed in the first 6 months after initiation of interferon therapy. In 18.3% of these patients the condition was temporary, while 3.2% patients required treatment for TD. The most frequently seen condition are subclinical types. Age (over 40 years) (OR: 7.25 95% CI = 1.46–35.80, P = 0.015) and gender (female) (OR: 5.83 95% CI = 1.31-25.76, P = 0.020) were found to be statistically significant independent risk factors in TD development.
Conclusion: Although TD secondary to interferon treatment in patients with CHB-C may develop in a substantial rate, most of these are temporary and do not require TD treatment. Independent risk factors in TD development were found to be gender and age.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.
Our 7 faculties and 12 professional schools offer more than 200 programmes to some 18,000 graduate, undergraduate and continuing studies students.
The UWI, Mona ranks first in Jamaica among accredited tertiary-level programmes. In 2012, the University was again one of Jamaica’s Top 100 Employers.
